Stifel analyst Bradley Canino reiterated a Buy rating and $20.00 price target on ORIC Pharamceuticals (NASDAQ: ORIC).The analyst commented, “Comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE